Stereotactic radiotherapy for lung cancer using a flattening filter free clinac

Journal of Applied Clinical Medical Physics

Volumn 10, Issue 1, 2009, Pages 14-21

  Vassiliev, Oleg N ^a   Kry, Stephen F ^a   Chang, Joe Y ^a   Balter, Peter A ^a   Titt, Uwe ^a   Mohan, Radhe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clinical linear accelerator; Flattening filter; Lung cancer; Stereotactic radiotherapy

Indexed keywords

ARTICLE; EQUIPMENT; FEASIBILITY STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG TUMOR; MEGAVOLTAGE RADIOTHERAPY; METHODOLOGY; RADIATION DOSE; RADIOSURGERY;

FEASIBILITY STUDIES; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 70049115354     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v10i1.2880     Document Type: Article

References (30)

1. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998;82(6):1062-70.
2. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I nonsmall cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys. 2001;51(3):666-70.
3. Wulf J, Haedinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001;177(12):645-55.
4. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002;52(4):1041-46.
5. Fukumoto S, Shirato H, Shimizu S, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer. 2002;95(7):1546-53.
6. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124(5):1946-55.
7. Hof H, Herfarth KK, Munter M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2003;56(2):335-341.
8. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer. 2004;101(7):1623-31.
9. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186-96.
10. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48(1):107-14.
11. McGarry RC, Papiez L, Williams M, Whitford T, Timmermann RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63(4):1010-15.
12. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427-31.
13. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66(1):117-25.
14. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) nonsmall-cell lung cancer (NSCLC). Acta Oncol. 2006;45(7):796-801.
15. Beitler JJ, Badine EA, El-Sayah D, et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys. 2006;65(1):100-106.
16. Nyman J, Johansson K, Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer. 2006;51(1):97-103.
17. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45(7):787-95.
18. Hara R, Itami J, Kondo T, et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer. 2006;106(6):1347-52.
19. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol. 2007;2(7 Suppl 3):S101-S112.
20. Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer. 2007;110(1):148-55.
21. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys. 2006;33(10):3874-3900.
22. Titt U, Vassiliev ON, Pönisch F, Dong L, Liu H, Mohan R. A flattening filter free photon treatment concept evaluation with Monte Carlo. Med Phys. 2006;33(6):1595-1602.
23. Vassiliev ON, Titt U, Pönisch F, Kry SF, Mohan R, Gillin MT. Dosimetric properties of photon beams from a flattening filter-free clinical accelerator. Phys Med Biol. 2006;51(7):1907-17.
24. Vassiliev ON, Titt U, Kry SF, Pönisch F, Gillin MT, Mohan R. Monte Carlo study of photon fields from a flattening filter-free clinical accelerator. Med Phys. 2006;33(4):820-27.
25. Kry SF, Titt U, Pönisch F, et al. Reduced neutron production through use of a flattening-filter-free accelerator. Int J Radiat Oncol Biol Phys. 2007;68(4):1260-64.
26. Kry SF, Howell RM, Titt U, Salehpour M, Mohan R, Vassiliev ON. Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac. Med Phys. 2008;35(5):1906-11.
27. Vassiliev ON, Kry SF, Kuban DA, Salehpour M, Mohan R, Titt U. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter. Int J Radiat Oncol Biol Phys. 2007;68(5):1567-71.
28. Ding M, Newman F, Kavanagh BD, et al. Comparative dosimetric study of three-dimensional conformal, dynamic confromal arc, and intensity-modulated radiotherapy for brain tumor treatment using Novalis system. Int J Radiat Oncol Biol Phys. 2006;66(4):S82-S86.
29. th Annual Meeting, Orlando FL, July 30-Aug.3 2006. Med Phys. 2006;33(6):2292.
30. Hanley J, Debois MM, Mah D, et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys. 1999;45(3):603-11.